June 7, 2022 MetasTx LLC Secures Funding and Partners with J-STAR Research BASKING RIDGE, N.J., June 07, 2022 (GLOBE NEWSWIRE) -- MetasTx LLC is driven to create novel therapeutics...
March 17, 2022 Join the 3rd Fundamentals of Solid Formulation Webinar Series 2022 J-STAR Research is pleased to announce our collaboration in the 3rd Edition of Fundamentals of...
March 11, 2022 Porton to Acquire China Gateway Pharmaceutical Development Co., Ltd. Expand small and medium-scale CDMO production capacity March 10th, 2022, Shanghai · China - Porton...
March 2, 2022 Porton to Invest $420 Million to Boost Small Molecule API Production March 1st, 2022, Chongqing · China – Porton Pharma Solutions Ltd. announced an investment of...
February 10, 2022 Porton Invests To Expand API CDMO Capacity Chongqing China, February 10, 2022--Porton Pharma Solutions Ltd. (Porton) today announced it will expand its...
January 20, 2022 Porton Expects Strongly Growth In Revenue And Net Profit In 2021 Chongqing · China: On January 16, 2022, Porton Pharma Solutions Ltd. released the "2021 Annual...
November 5, 2021 Porton and Honeywell Collaborate to Create a Leading CDMO Platform Subtitle: Enabling Public’s Early Access to Good Medicines On November 6,...
October 13, 2021 J-STAR Research Experts to Present at AAPS PharmSci360 2021 J-STAR Research’s subject matter experts are presenting at 2021 AAPS PharmSci360, in Philadelphia, PA, on...